Table 3.
Differentially Abundant Bacterial Amplicon Sequence Variants in SARS-CoV-2–Infected and Uninfected Participants in GJAM Analyses
| ASV | Bacterial Species | Age | SARS-CoV-2 Infection | Age × SARS-CoV-2 Infection | |||
|---|---|---|---|---|---|---|---|
| Estimate | (95% CI) | Estimate | (95% CI) | Estimate | (95% CI) | ||
| 306 | Moraxella nonliquefaciens | −.020 | (−.023, −.016) | −.108 | (−.158, −.055) | .005 | (.001, .009) |
| 629 | Prevotella nanceiensis | −.002 | (−.003, −.001) | −.022 | (−.037, −.006) | .002 | (.0003, .003) |
| 692 | Prevotella intermedia | −.002 | (−.003, −.0004) | −.020 | (−.038, −.001) | NS | NS |
| 712 | Prevotella melaninogenica | −.002 | (−.003, −.0009) | −.016 | (−.032, −.0006) | .001 | (.0007, .0002) |
| 1095 | Corynebacterium tuberculostearicum | .006 | (.004, .007) | .022 | (.002, .041) | −.003 | (−.004, −.001) |
| 1163 | Corynebacterium propinquum | −.004 | (−.007, −.0002) | .090 | (.040, .142) | −.004 | (−.009, −.0004) |
| 1165 | Corynebacterium propinquum | NS | NS | −.033 | (−.059, −.007) | .003 | (.001, .006) |
| 1488 | Streptococcus mitis | −.002 | (−.004, −.001) | −.202 | (−.038, −.002) | NS | NS |
| 1581 | Gemella morbillorum | −.003 | (−.004, −.001) | −.022 | (−.040, −.003) | .002 | (.0003, .003) |
ASV, amplicon sequence variant; CI, confidence interval; GJAM, generalized joint attribute modeling; NS, not significant; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.